Connect Biopharma Holdings (CNTB)
(Delayed Data from NSDQ)
$2.00 USD
-0.02 (-0.99%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.00 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Connect Biopharma Holdings Limited Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CNTB 2.00 -0.02(-0.99%)
Will CNTB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CNTB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNTB
What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
CNTB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CNTB
Connect Biopharma (CNTB) Expands Board with New Director Appointment | CNTB Stock News
Connect Biopharma (CNTB) Gains Attention with Promising Treatment | CNTB Stock News
Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors | CNTB ...
Northland Begins Coverage on Connect Biopharma (CNTB) with Positive Outlook | CNTB Stock News
Connect Biopharma announces expansion of board, appoints Schoeneck as director